View in EDS

Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.

Saved in:
Bibliographic Details
Title: Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
Authors: Sayan, M.1 (AUTHOR), Vergalasova, I.2 (AUTHOR), Jhawar, S.R.3 (AUTHOR), Toppmeyer, D.1 (AUTHOR), Haffty, B.G.1 (AUTHOR), Ohri, N.1 (AUTHOR)
Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE31-E32. 2p.
Subjects: Epidermal growth factor receptors, Lumpectomy, Prothrombin, Hormone receptor positive breast cancer
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2019.06.688